Adiponectin as a new paradigm for approaching Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Adiponectin as a new paradigm for approaching Alzheimer's disease.

Adiponectin as a new paradigm for approaching Alzheimer's disease.

http://www.wikidata.org/entity/Q37420289

about

Association between risk factors for vascular dementia and adiponectin.Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus.Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.Adiponectin and migraine: systematic review of clinical evidence.Body mass index in dementia.Vascular biomarkers in migraine.Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.Cognitive decline, mortality, and organophosphorus exposure in aging Mexican Americans.Intracerebroventricular Streptozotocin Induces Obesity and Dementia in Lewis Rats.The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease.Association of adiponectin with cognitive function precedes overt diabetes in the Brazilian Longitudinal Study of Adult Health: ELSA.

P2860

Q33594133-28D0C483-6CF5-49A3-88C7-12826E15D51E Q35793436-3C541BF5-FC0B-4AED-A5C5-AA5F7E26225B Q37114306-28748DC2-39FB-4C15-B711-50FF84D3FA30 Q38197550-74600A5F-DBB7-45A9-B533-FF07EE1A8A13 Q38255757-4669FD59-3CC6-4FED-A0FC-DAC89C80B198 Q38256564-A1824E23-BF43-459A-B3F7-186C283E8FBA Q41039610-B69D09E0-B0B4-4EE0-91D7-7F64A9C93CBF Q46115592-118E9B78-9D7E-4557-8F59-D89C1065F181 Q47649415-ACE7057F-D0C5-4EA1-A5AD-A9EFB8170E33 Q50041710-BA2DC7A5-F18D-497A-B5F2-170E289F6D28 Q55693242-8DCAEF38-4502-4C5C-A898-018F9B182A72

P2860

Adiponectin as a new paradigm for approaching Alzheimer's disease.

http://www.wikidata.org/entity/Q37420289

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adiponectin as a new paradigm for approaching Alzheimer's disease.

@en

Adiponectin as a new paradigm for approaching Alzheimer's disease.

@nl

type

label

Adiponectin as a new paradigm for approaching Alzheimer's disease.

@en

Adiponectin as a new paradigm for approaching Alzheimer's disease.

@nl

prefLabel

Adiponectin as a new paradigm for approaching Alzheimer's disease.

@en

Adiponectin as a new paradigm for approaching Alzheimer's disease.

@nl

P1433

Q37420289-F879392F-3AB6-4E4F-BF65-6A8F6D35D0E7

P1476

Q37420289-1FDF41C9-90EF-4DCD-BD21-524710A8FA22

P2093

Q37420289-DCE6BF4E-F539-4D23-9458-D86B2AF8A3B2

P2860

Q37420289-08642A50-69AA-4985-8281-DD43870960C4

Q37420289-098D4830-B26B-4678-A41E-721272E036B4

Q37420289-11EC0BBA-3104-4422-B8C0-6929AE0BBBE2

Q37420289-122CF8C1-941E-4693-8759-D7EF8AE4131D

Q37420289-13F3C675-F0A7-4FCA-AD59-1C7E44DE106B

Q37420289-177C855F-0823-4BBC-A2A1-831A767A255B

Q37420289-1A2F1AC9-45E7-406D-9167-258EB584EAF1

Q37420289-1D4F3F58-5876-4BF0-9FE7-9C942FBBBDC3

Q37420289-1EC7B637-3434-40CC-9D28-B2F8FD6BFE68

Q37420289-1FA62E79-8E5B-454F-911D-8213167EA1DE

P304

Q37420289-F242B197-7D45-4C05-B737-C11F72685CFB

P31

Q37420289-868F3345-9708-44D1-BAA1-A30E21F961B5

P356

Q37420289-CE78E1EA-5A7C-4BA9-AE34-2A388BBDB9B9

P433

Q37420289-5FE4C265-2335-416E-8C32-700B846FF1E4

P478

Q37420289-8CBD0F13-1C44-475F-8DE4-A9CE2A8CDC0F

P50

Q37420289-8EFD8ABC-5C15-40E7-9F9A-DB30F4920503

P577

Q37420289-797354A3-2B97-4753-B1D0-AE4EB5DF7399

P5875

Q37420289-10B2E1A8-7D42-4F52-BDAD-B6F37E0FDA51

P698

Q37420289-663EE8CE-122C-4FC7-84CC-DED8DF061A0C

P921

Q37420289-FD59A3B5-F4D6-45E7-AA44-4A19DFFDCB5F

P932

Q37420289-8CE76BD4-FF9D-4C96-B28A-E54899BD2AA5

P356

ACB.2013.46.4.229

P1433

Anatomy & cell biology

P1476

Adiponectin as a new paradigm for approaching Alzheimer's disease

@en

P2093

Juhyun Song

http://www.w3.org/2001/XMLSchema#string

P2860

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders

Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

Disruption of adiponectin causes insulin resistance and neointimal formation

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

Adiponectin and adiponectin receptors

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes

P304

229-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5115/ACB.2013.46.4.229

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259568081

http://www.w3.org/2001/XMLSchema#string

P698

24386594

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3875839

http://www.w3.org/2001/XMLSchema#string